Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intrathecal Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells for Children With Cerebral Palsy
Sponsor: Gadjah Mada University
Summary
This is a single-center, open-label, single-arm Phase I pilot study designed to evaluate the feasibility and short-term safety of a single intrathecal administration of allogeneic umbilical cord tissue-derived mesenchymal stromal cells (UCT-MSCs) in children with cerebral palsy (CP).
Official title: Intrathecal Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Children With Cerebral Palsy: A Pilot Study of Feasibility, Short-Term Safety, and Exploratory Outcomes
Key Details
Gender
All
Age Range
2 Years - 5 Years
Study Type
INTERVENTIONAL
Enrollment
7
Start Date
2024-12-01
Completion Date
2026-09
Last Updated
2026-08-13
Healthy Volunteers
No
Conditions
Interventions
allogeneic umbilical cord tissue-derived mesenchymal stromal cells (UCT-MSCs)
A single intrathecal dose of allogeneic umbilical cord tissue-derived mesenchymal stromal cells (UCT-MSCs) at 2 × 10⁶ viable cells/kg body weight
Locations (1)
Dr. Sardjito Hospital
Yogyakarta, D.I. Yogyakarta, Indonesia